Cynosure Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
5,759
+1,544
| +37% | +$122K | 0.05% | 198 |
|
|
2025
Q1 | $378K | Buy |
4,215
+671
| +19% | +$60.2K | 0.05% | 176 |
|
|
2024
Q4 | $353K | Sell |
3,544
-710
| -17% | -$70.6K | 0.05% | 166 |
|
|
2024
Q3 | $483K | Buy |
4,254
+656
| +18% | +$74.5K | 0.07% | 162 |
|
|
2024
Q2 | $445K | Buy |
3,598
+377
| +12% | +$46.7K | 0.07% | 152 |
|
|
2024
Q1 | $425K | Sell |
3,221
-25,866
| -89% | -$3.41M | 0.08% | 133 |
|
|
2023
Q4 | $3.17M | Buy |
29,087
+18,645
| +179% | +$2.03M | 0.57% | 45 |
|
|
2023
Q3 | $1.08M | Sell |
10,442
-134
| -1% | -$13.8K | 0.33% | 70 |
|
|
2023
Q2 | $1.22M | Buy |
+10,576
| New | +$1.22M | 0.37% | 61 |
|